IUUS:LSE:LSE- (USD)

ETF | Others |

Last Closing

USD 9.5625

Change

+0.06 (+0.67)%

Market Cap

USD 0.50B

Volume

0.39M
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNIF:LSE Xtrackers Nifty 50 Swap UCITS ..

+72.50 (+0.36%)

USD 292,109.69B
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

+1.91 (+0.73%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

+0.20 (+0.10%)

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.10 (-0.58%)

USD 701.81B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.12 (-0.84%)

USD 636.56B
0R1I:LSE NVIDIA Corp.

-0.48 (-0.43%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+0.15 (+0.21%)

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

-0.16 (-0.54%)

USD 259.48B
0QZO:LSE 0QZO

-0.05 (-0.05%)

USD 258.54B

ETFs Containing IUUS:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.71% 77% C+ 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.71% 76% C+ 71% C-
Trailing 12 Months  
Capital Gain 24.03% 93% A 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.03% 92% A 86% B+
Trailing 5 Years  
Capital Gain 69.73% 55% F 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 69.73% 52% F 62% D
Average Annual (5 Year Horizon)  
Capital Gain 8.97% 59% D- 64% D
Dividend Return 8.97% 58% F 63% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.17% 52% F 70% C-
Risk Adjusted Return 68.09% 67% D+ 79% B-
Market Capitalization 0.50B 72% C 43% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike